Single cell deciphering of pruritic keloids: the interaction between fibroblasts and Schwann cells through the Midkine signaling

Abstract

Background: Keloids are a common skin fibroproliferative disease that can result in severe aesthetic and functional concerns. Pruritus and pain are the most prevalent clinical manifestations of keloids. Schwann cells (SCs) variation and neuropathy within keloids contribute to these uncomfortable sensations; however the underlying mechanisms remain unclear. This study aims to explore the potential role of fibroblasts (FBs) and SCs in pruritic and pain keloids. Methods: The activity of FBs and SCs was investigated using single-cell RNA sequencing (scRNA-seq) data of keloids. These bioinformatics analysis results were validated through in vitro cell culture, clinical samples, and in vivo experiments. The selected molecule was confirmed to be correlated with pain and itch and was subsequently used to treat cells in order to investigate its role in keloids. The in vivo inhibition assay was performed to evaluate its therapeutic potential. Results: Our scRNA-seq analysis identified specific types of FBs and SCs were present in higher proportions in keloids and exhibited neurogenesis-related functions. Upon conducting an interaction analysis of these two cell types, we identified a critical molecule, Midkine (MDK), which is positively correlated with the patients’ pain and itching levels. Besides, MDK treatment facilitated the proliferation of SCs and their transition to a repairing phenotype, resulting in neuronal axonogenesis. This activation of repairing SCs promoted the release of substance P from nerve fibers, leading to clinical symptoms of pain and pruritus in keloid patients. Targeting MDK effectively reduces abnormal Schwann cell proliferation and subsequently inhibits the secretion of neuropeptides that trigger pain and pruritus. Conclusions: Our study uncovered the interaction between FBs and SCs in the development of keloidal pain and pruritus, offering a novel therapeutic strategy to alleviate the distressing symptoms of keloids.

Keywords

Single-cell transcriptome / Keloids / Fibroblasts / Schwann cells / Neurogenesis

References

[1] Andrews JP, Marttala J, Macarak E, Rosenbloom J, Uitto J. Keloids: the paradigm of skin fibrosis-Pathomechanisms and treatment.Matrix Biol 2016; 51: 37-46. https://doi.org/10.1016/j.matbio.2016.01.013.

[2] Sheng M, Chen Y, Li H, Zhang Y, Zhang Z. The application of corticosteroids for pathological scar prevention and treatment: current review and update. Burns & Trauma 2023; 11: 11. https://doi.org/10.1093/burnst/tkad009.

[3] Bijlard E, Kouwenberg CA, Timman R, Hovius SE, Busschbach JJ, Mureau MA. Burden of keloid disease: a cross-sectional health-related quality of life assessment. Acta Derm Venereol 2017; 97: 225-9. https://doi.org/10.2340/00015555-2498.

[4] Kassi K, Kouame K, Kouassi A, Allou A, Kouassi I, Kourouma S, et al. Quality of life in black African patients with keloid scars. Dermatol Reports 2020; 12: 8312. https://doi.org/10.4081/dr.2020.8312.

[5] Xia Y, Wang Y, Shan M, Hao Y, Liang Z. Decoding the molecular landscape of keloids: new insights from single-cell transcriptomics. Burns Trauma 2023; 11: tkad017. https://doi.org/10.1093/burnst/tkad017.

[6] Deng CC, Hu YF, Zhu DH, Cheng Q, Gu JJ, Feng QL, et al. Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases. Nat Commun 2021; 12: 3709. https://doi.org/10.1038/s41467-021-24110-y.

[7] Liu X, Chen W, Zeng Q, Ma B, Li Z, Meng T, et al. Single-cell RNA-sequencing reveals lineage-specific regulatory changes of fibroblasts and vascular endothelial cells in keloids. J Invest Dermatol 2022; 142: 124-35 e11. https://doi.org/10.1016/j.jid.2021.06.010.

[8] Shim J, Oh SJ, Yeo E, Park JH, Bae JH, Kim SH, et al. Integrated analysis of single-cell and spatial transcriptomics in keloids: highlights on fibrovascular interactions in keloid pathogenesis. J Invest Dermatol 2022; 142: 2128-39 e11. https://doi.org/10.1016/j.jid.2022.01.017.

[9] Direder M, Weiss T, Copic D, Vorstandlechner V, Laggner M, Pfisterer K, et al. Schwann cells contribute to keloid formation. Matrix Biol 2022; 108: 55-76. https://doi.org/10.1016/j.matbio.2022.03.001.

[10] Direder M, Wielscher M, Weiss T, Laggner M, Copic D, Klas K, et al. The transcriptional profile of keloidal Schwann cells. Exp Mol Med 2022; 54: 1886-900. https://doi.org/10.1038/s12276-022-00874-1.

[11] Yampolsky M, Bachelet I, Fuchs Y. Reproducible strategy for excisional skin-wound-healing studies in mice. Nat Protoc 2024; 19: 184-206. https://doi.org/10.1038/s41596-023-00899-4.

[12] Wu Y, Su K, Zhang Y, Liang L, Wang F, Chen S, et al. A spatiotemporal transcriptomic atlas of mouse placentation. Cell Discov 2024; 10: 110. https://doi.org/10.1038/s41421-024-00740-6.

[13] Liu L, Yu H, Long Y, You Z, Ogawa R, Du Y, et al. Asporin inhibits collagen matrix-mediated intercellular mechanocommunications between fibroblasts during keloid progression. FASEB J 2021; 35: e21705. https://doi.org/10.1096/fj.202100111R.

[14] Dong Y, Zhang C, Zhang Q, Li Z, Wang Y, Yan J, et al. Identification of nanoparticle-mediated siRNA-ASPN as a key gene target in the treatment of keloids. Front Bioeng Biotechnol 2022; 10: 1025546. https://doi.org/10.3389/fbioe.2022.1025546.

[15] Goncalves NP, Vaegter CB, Andersen H, Ostergaard L, Calcutt NA, Jensen TS. Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat Rev Neurol 2017; 13: 135-47. https://doi.org/10.1038/nrneurol.2016.201.

[16] Gillespie CS, Lee M, Fantes JF, Brophy PJ. The gene encoding the Schwann cell protein periaxin localizes on mouse chromosome 7 (Prx). Genomics. 1997; 41: 297-8. https://doi.org/10.1006/geno.1997.4630.

[17] Bargagna-Mohan P, Schultz G, Rheaume B, Trakhtenberg EF, Robson P, Pal-Ghosh S, et al. Corneal nonmyelinating Schwann cells illuminated by single-cell transcriptomics and visualized by protein biomarkers. J Neurosci Res 2021; 99: 731-49. https://doi.org/10.1002/jnr.24757.

[18] Han H, Kursula P. Expression, purification, crystallization and preliminary X-ray crystallographic analysis of the extracellular olfactomedin domain of gliomedin. Acta Crystallogr F Struct Biol Commun 2014; 70: 1536-9. https://doi.org/10.1107/S2053230X14020305.

[19] Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun 2021; 12: 1088. https://doi.org/10.1038/s41467-021-21246-9.

[20] Wong LS, Lee CH, Yen YT. Increased epidermal nerve growth factor without small-Fiber neuropathy in dermatomyositis. Int J Mol Sci 2022; 23. https://doi.org/10.3390/ijms23169030.

[21] Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005; 114: 29-36. https://doi.org/10.1016/j.pain.2004.12.010.

[22] Reich A, Bozek A, Janiszewska K, Szepietowski JC. 12-item pruritus severity scale: development and validation of new itch severity questionnaire. Biomed Res Int 2017; 2017: 1-7. https://doi.org/10.1155/2017/3896423.

[23] Jessen KR, Arthur-Farraj P. Repair Schwann cell update: adaptive reprogramming, EMT, and stemness in regenerating nerves. Glia. 2019; 67: 421-37. https://doi.org/10.1002/glia.23532.

[24] Nocera G, Jacob C. Mechanisms of Schwann cell plasticity involved in peripheral nerve repair after injury. Cell Mol Life Sci 2020; 77: 3977-89. https://doi.org/10.1007/s00018-020-03516-9.

[25] Kuruvilla M, Kalangara J, Lee FEE. Neuropathic pain and itch mechanisms underlying allergic conjunctivitis. J Investig Allergol Clin Immunol 2019; 29: 349-56. https://doi.org/10.18176/jiaci.0320.

[26] Hawash AA, Ingrasci G, Nouri K, Yosipovitch G. Pruritus in keloid scars: mechanisms and treatments. Acta Derm Venereol 2021; 101: adv00582. https://doi.org/10.2340/00015555-3923.

[27] Ogawa R, Akita S, Akaishi S, Aramaki-Hattori N, Dohi T, Hayashi T, et al. Diagnosis and treatment of keloids and hypertrophic scars-Japan scar workshop consensus document 2018. Burns Trauma 2019; 7: 39. https://doi.org/10.1186/s41038-019-0175-y.

[28] Frech FS, Hernandez L, Urbonas R, Zaken GA, Dreyfuss I, Nouri K. Hypertrophic scars and keloids: advances in treatment and review of established therapies. Am J Clin Dermatol 2023; 24: 225-45. https://doi.org/10.1007/s40257-022-00744-6.

[29] Jeschke MG, Wood FM, Middelkoop E, Bayat A, Teot L, Ogawa R, et al. Scars. Scars Nat Rev Dis Primers 2023; 9: 64. https://doi.org/10.1038/s41572-023-00474-x.

[30] Xu W, Sinaki DG, Tang Y, Chen Y, Zhang Y, Zhang Z. Acne-induced pathological scars: pathophysiology and current treatments. Burns & Trauma 2024; 12: 12. https://doi.org/10.1093/burnst/tkad060.

[31] Zhang M, Chen H, Qian H, Wang C. Characterization of the skin keloid microenvironment. Cell Commun Signal 2023; 21: 207. https://doi.org/10.1186/s12964-023-01214-0.

[32] Chipev CC, Simman R, Hatch G, Katz AE, Siegel DM, Simon M. Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro. Cell Death Differ 2000; 7: 166-76. https://doi.org/10.1038/sj.cdd.4400605.

[33] Huang Y, Pu W, Wang L, Ma Q, Ma Y, Liu Q, et al. Atypical chemokine receptor 1-positive endothelial cells mediate leucocyte infiltration and synergize with secreted frizzled-related protein 2/asporin-positive fibroblasts to promote skin fibrosis in systemic sclerosis. Br J Dermatol 2024; 191: 964-78. https://doi.org/10.1093/bjd/ljae286.

[34] Medzikovic L, Aryan L, Ruffenach G, Li M, Savalli N, Sun W, et al. Myocardial fibrosis and calcification are attenuated by microRNA-129-5p targeting Asporin and Sox9 in cardiac fibroblasts. JCI.Insight. 2023; 8: 8. https://doi.org/10.1172/jci.insight.168655.

[35] Huang X, Zhao X, Li Y, Feng Y, Zhang G, Wang Q, et al. Combining bulk and single cell RNA-sequencing data to identify hub genes of fibroblasts in dilated cardiomyopathy. J Inflamm Res 2024; 17: 5375-88. https://doi.org/10.2147/JIR.S470860.

[36] Mayr CH, Santacruz D, Jarosch S, Bleck M, Dalton J, McNabola A, et al. Spatial transcriptomic characterization of pathologic niches in IPF. Sci Adv 2024; 10: eadl5473. https://doi.org/10.1126/sciadv.adl5473.

[37] Hochman B, Nahas FX, Sobral CS, Arias V, Locali RF, Juliano Y, et al. Nerve fibres: a possible role in keloid pathogenesis. Br J Dermatol 2008; 158: 651-2. https://doi.org/10.1111/j.1365-2133.2007.08401.x.

[38] Chen B, Banton MC, Singh L, Parkinson DB, Dun XP. Single cell transcriptome data analysis defines the heterogeneity of peripheral nerve cells in homeostasis and regeneration. Front Cell Neurosci 2021; 15: 624826. https://doi.org/10.3389/fncel.2021.624826.

[39] Li M, Banton MC, Min Q, Parkinson DB, Dun X. Meta-analysis reveals transcription factor upregulation in cells of injured mouse sciatic nerve. Front Cell Neurosci 2021; 15: 688243. https://doi.org/10.3389/fncel.2021.688243.

[40] Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011; 17: 113-25. https://doi.org/10.2119/molmed.2009.00153.

[41] Zhang L, Xie R, Yang J, Zhao Y, Qi C, Bian G, et al. Chronic pain induces nociceptive neurogenesis in dorsal root ganglia from Sox2-positive satellite cells. Glia. 2019; 67: 1062-75. https://doi.org/10.1002/glia.23588.

[42] Garcia-Gonzalez D, Dumitru I, Zuccotti A, Yen TY, Herranz-Perez V, Tan LL, et al. Neurogenesis of medium spiny neurons in the nucleus accumbens continues into adulthood and is enhanced by pathological pain. Mol Psychiatry 2021; 26: 4616-32. https://doi.org/10.1038/s41380-020-0823-4.

[43] Cai X, Han M, Lou F, Sun Y, Yin Q, Sun L, et al. Tenascin C(+) papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis. Nat Commun 2023; 14: 2004. https://doi.org/10.1038/s41467-023-37798-x.

[44] Dreesmann L, Mittnacht U, Lietz M, Schlosshauer B. Nerve fibroblast impact on Schwann cell behavior. Eur J Cell Biol 2009; 88: 285-300. https://doi.org/10.1016/j.ejcb.2009.01.001.

[45] Zhang Z, Yu B, Gu Y, Zhou S, Qian T, Wang Y, et al. Fibroblast-derived tenascin-C promotes Schwann cell migration through beta1-integrin dependent pathway during peripheral nerve regeneration. Glia. 2016; 64: 374-85. https://doi.org/10.1002/glia.22934.

[46] Parrinello S, Napoli I, Ribeiro S, Wingfield Digby P, Fedorova M, Parkinson DB, et al. EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting. Cell. 2010; 143: 145-55. https://doi.org/10.1016/j.cell.2010.08.039.

[47] Takada S, Sakakima H, Matsuyama T, Otsuka S, Nakanishi K, Norimatsu K, et al. Disruption of Midkine gene reduces traumatic brain injury through the modulation of neuroinflammation. J Neuroinflammation 2020; 17: 40. https://doi.org/10.1186/s12974-020-1709-8.

[48] Filippou PS, Karagiannis GS, Constantinidou A. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene. 2020; 39: 2040-54. https://doi.org/10.1038/s41388-019-1124-8.

[49] Yoshida Y, Sakakima H, Matsuda F, Ikutomo M. Midkine in repair of the injured nervous system. Br J Pharmacol 2014; 171: 924-30. https://doi.org/10.1111/bph.12497.

[50] Nattkemper LA, Fourzali K, Yosipovitch G. Cutaneous gene expression in primates with itch. J Invest Dermatol 2021; 141: 1586-8. https://doi.org/10.1016/j.jid.2020.11.017.

[51] Ueno M, Kariya R, Gunya S, Cheevapruk K, Okada S. Midkine inhibitor (iMDK) induces apoptosis of primary effusion lymphoma via G2/M cell cycle arrest. Leuk Res 2022; 116: 106826. https://doi.org/10.1016/j.leukres.2022.106826.

[52] Liu Q, Tan J, Zhao Z, Li R, Zheng L, Chen X, et al. Combined usage of MDK inhibitor augments interferon-γ anti-tumor activity in the SKOV3 human ovarian cancer cell line. Biomedicines. 2022; 11: 11. https://doi.org/10.3390/biomedicines11010008.

[53] Masui M, Okui T, Shimo T, Takabatake K, Fukazawa T, Matsumoto K, et al. Novel Midkine inhibitor iMDK inhibits tumor growth and angiogenesis in oral squamous cell carcinoma. Anticancer Res 2016; 36: 2775-81.